Birgitta Grundmark Selected Research

N-retinoyl-O-phosphotyrosine

11/2002

Cytotoxic activity of a new lipid formulation of doxorubicin in cell lines and primary tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Birgitta Grundmark Research Topics

Disease

3	Drug-Related Side Effects and Adverse Reactions 01/2020 - 05/2014
2	Prostatic Neoplasms (Prostate Cancer) 02/2017 - 10/2011
2	Narcolepsy 04/2015 - 05/2013
2	Neoplasms (Cancer) 11/2008 - 11/2002
1	COVID-19 01/2021
1	Bradycardia 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Sleepiness 09/2018
1	Hallucinations (Hallucination) 09/2018
1	Lymphoma (Lymphomas) 01/2018
1	Human Influenza (Influenza) 04/2015
1	Shock 04/2015
1	Type 2 Diabetes Mellitus (MODY) 05/2014
1	Ovarian Epithelial Carcinoma 02/2014

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2020 - 02/2014
2	Metformin (Glucophage)FDA LinkGeneric 02/2017 - 05/2014
1	remdesivirIBA 01/2021
1	desloratadine (Aerius)FDA LinkGeneric 09/2018
1	Histamine Antagonists (Antihistamines)IBA 09/2018
1	Natalizumab (Tysabri)FDA Link 01/2018
1	Insulin (Novolin)FDA Link 02/2017
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 04/2015
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 04/2015
1	pandemrixIBA 04/2015
1	VaccinesIBA 04/2015
1	bicalutamide (Casodex)FDA LinkGeneric 05/2014
1	VildagliptinIBA 05/2014
1	abirateroneIBA 05/2014
1	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2013
1	SeleniumIBA 10/2011
1	Gefitinib (Iressa)FDA Link 11/2008
1	N-retinoyl-O-phosphotyrosineIBA 11/2002
1	LipidsIBA 11/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2002